Physician profile
Ryan S Reeves
NPI 1669406724
$14,715.78
in general payments reported to CMS, 2019-2025
8 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $72.68 · 2021: $166 · 2022: $11K · 2023: $1,471 · 2024: $1,123 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262 · Consulting Fee: $1,225 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.51 |
| Consulting Fee | $1,225.00 |
| Travel and Lodging | $497.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $12,962.74 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $1,396.22 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Mml US, INC. | $124.97 | 2025 | Reactiv8 |
| Abbott Laboratories | $93.92 | 2019 | |
| Medtronic USA, INC. | $55.05 | 2019-2020 | |
| Nevro Corp. | $34.44 | 2024 | Senza |
| Si-Bone, INC. | $24.34 | 2024 | |
| Medtronic, INC. | $24.10 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.